Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 22278196)

1.

Quantitative RT-PCR analysis of the MOZ-CBP fusion transcript in therapy-related acute myeloid leukemia with t(8;16)(p11;p13).

Fujiki A, Imamura T, Furutani A, Hatano W, Asai D, Hirashima Y, Miyachi M, Tamura S, Tsuchiya K, Iehara T, Ishida H, Yoshihara T, Hosoi H.

J Pediatr Hematol Oncol. 2012 Jul;34(5):402-5. doi: 10.1097/MPH.0b013e318238818f.

PMID:
22278196
2.

RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).

Panagopoulos I, Isaksson M, Lindvall C, Björkholm M, Ahlgren T, Fioretos T, Heim S, Mitelman F, Johansson B.

Genes Chromosomes Cancer. 2000 Aug;28(4):415-24.

PMID:
10862050
3.

RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.

Schmidt HH, Strehl S, Thaler D, Strunk D, Sill H, Linkesch W, Jäger U, Sperr W, Greinix HT, König M, Emberger W, Haas OA.

Leukemia. 2004 Jun;18(6):1115-21.

PMID:
15085163
4.

Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts.

Takenokuchi M, Yasuda C, Takeuchi K, Nakamachi Y, Mukai M, Kondo S, Kumagai S, Saigo K, Murayama T, Koizumi T, Tatsumi E.

Clin Lab Haematol. 2004 Apr;26(2):107-14.

PMID:
15053804
5.

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR.

Sugimoto T, Das H, Imoto S, Murayama T, Gomyo H, Chakraborty S, Taniguchi R, Isobe T, Nakagawa T, Nishimura R, Koizumi T.

Am J Hematol. 2000 Jun;64(2):101-6.

PMID:
10814988
6.

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.

Rozman M, Camós M, Colomer D, Villamor N, Esteve J, Costa D, Carrió A, Aymerich M, Aguilar JL, Domingo A, Solé F, Gomis F, Florensa L, Montserrat E, Campo E.

Genes Chromosomes Cancer. 2004 Jun;40(2):140-5.

PMID:
15101047
7.

RT-PCR analysis of acute myeloid leukemia with t(8;16)(p11;p13): identification of a novel MOZ/CBP transcript and absence of CBP/MOZ expression.

Panagopoulos I, Fioretos T, Isaksson M, Mitelman F, Johansson B, Theorin N, Juliusson G.

Genes Chromosomes Cancer. 2002 Dec;35(4):372-4. No abstract available.

PMID:
12378533
8.

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.

Krauter J, Gorlich K, Ottmann O, Lubbert M, Dohner H, Heit W, Kanz L, Ganser A, Heil G.

J Clin Oncol. 2003 Dec 1;21(23):4413-22.

PMID:
14645432
10.

Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.

Laczika K, Novak M, Hilgarth B, Mitterbauer M, Mitterbauer G, Scheidel-Petrovic A, Scholten C, Thalhammer-Scherrer R, Brugger S, Keil F, Schwarzinger I, Haas OA, Lechner K, Jaeger U.

J Clin Oncol. 1998 Apr;16(4):1519-25.

PMID:
9552061
11.

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.

Viehmann S, Teigler-Schlegel A, Bruch J, Langebrake C, Reinhardt D, Harbott J.

Leukemia. 2003 Jun;17(6):1130-6.

PMID:
12764380
12.

Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).

Panagopoulos I, Isaksson M, Lindvall C, Hagemeijer A, Mitelman F, Johansson B.

Genes Chromosomes Cancer. 2003 Jan;36(1):90-8.

PMID:
12461753
13.

Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.

Boyd EM, Bench AJ, Vaghela KJ, Campbell GN, Chowdhury FB, Gudgin EJ, Scott MA, Erber WN.

Leukemia. 2009 Jun;23(6):1164-7. doi: 10.1038/leu.2008.383. Epub 2009 Jan 22. No abstract available.

PMID:
19158836
14.
15.
16.
17.

The clinical utility of genetic testing for t(8;16)(p11;p13) in congenital acute myeloid leukemia.

Daifu T, Kato I, Kozuki K, Umeda K, Hiramatsu H, Watanabe K, Kamiya I, Taki T, Nakahata T, Heike T, Adachi S.

J Pediatr Hematol Oncol. 2014 Jul;36(5):e325-7. doi: 10.1097/MPH.0000000000000099.

PMID:
24390445
18.

New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.

Murati A, Adélaïde J, Quilichini B, Rémy V, Sainty D, Stoppa AM, Bernard P, Olschwang S, Birnbaum D, Chaffanet M, Mozziconacci MJ.

Haematologica. 2007 Feb;92(2):262-3.

19.

Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.

Kong XT, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N, Kaneko Y, Sako M, Kobayashi Y, Tojou A, Miura I, Kakuda H, Funabiki T, Horibe K, Hamaguchi H, Akiyama Y, Bessho F, Yanagisawa M, Hayashi Y.

Blood. 1997 Aug 1;90(3):1192-9.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk